openPR Logo

Press Releases from Diabetic nephropathy Market (2 total)

Diabetic Nephropathy market 2020 | Mitsubishi Tanabe Pharma Corporation, Novarti …

Diabetic nephropathy is known as the most significant impediment occurring in the kidney glomerulus which render the patient morbid or even worse in majority of the cases. Characterized by macroalbuminuria, diabetic nephropathy is diagnosed when more than 300 milligrams of albumin are present in the urine in a day. The global market for diabetic nephropathy was valued at US$ 2,262.2 million in 2014. Registering a steady CAGR of 5.6%, the

Diabetic nephropathy Therapeutic Pipeline Market Review, H1 2017

Summary Diabetic nephropathy is the damage to the kidney occurring due to diabetes. It is characterized by albuminuria, reduction in glomerular filtration rate and high blood pressure. Risk factors include obesity, hypertension, high lipid and sugar levels and smoking. This condition is managed by medication and dietary modification. GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1119729-diabetic-nephropathy-pipeline-review-h1-2017 Report Highlights Pharmaceutical and Healthcare latest pipeline guide Diabetic Nephropathy - Pipeline Review, H1 2017, provides comprehensive information on the

Go To Page:   1 2 3 4 5 6 7 8 9 10